$HUM

Jefferies raises Medicaid attrition forecast for August 2026

Jefferies reports Medicaid enrollment attrition rose to 0.5% in August 2026, exceeding the 2026 monthly average of 0.3%. Humana showed flat enrollment, while other MCOs like Centene, Elevance Health, Molina, and UnitedHealth are expected to report lower Q3 attrition. State policy changes contributed to enrollment churn, with Jefferies noting a morbidity shift due to disenrollment.

Original reporting
Published Sep 30, 2026, 9:26 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 9:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HUM
Neutral
medium confidence
Mentioned
$HUM · $CNC · $ELV · $MOH · $UNH
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HUMNeutralLow
01

Why it matters

The new attrition numbers provide fresh insight into enrollment dynamics, potentially affecting cost and revenue expectations for major health insurers.

02

Market read

The attrition forecast updates expectations for major U.S. health insurers, offering modest trading signals.

03

What to watch

State policy changes and economic conditions could alter future attrition beyond current forecasts.

Relevance 4/10Novelty 4/10Timing: today

Background

Jefferies released an updated Medicaid enrollment attrition forecast for August 2026, noting a rise to 0.5% and varying performance among major MCOs.

Company-level read

Ticker impact

$HUMNeutralMedium confidence
Context

Humana reported approximately flat Medicaid enrollment attrition in August, contrasting with peers.

Expected impact

likely modest upside as investors view stable enrollment favorably

Evidence & confidence

The report highlights Humana's better performance relative to other MCOs, suggesting less enrollment risk.

$CNCBullishMedium confidence
Context

Jefferies expects Centene to post lower quarter‑over‑quarter Medicaid attrition in Q3.

Expected impact

potential upward pressure as reduced churn is seen as a positive operational metric

Evidence & confidence

Analyst forecast of improved attrition signals better member retention.

$ELVBullishMedium confidence
Context

Jefferies expects Elevance Health to post lower quarter‑over‑quarter Medicaid attrition in Q3.

Expected impact

likely modest upside as investors price in better enrollment trends

Evidence & confidence

The forecast indicates a favorable shift in enrollment dynamics.

$MOHBullishMedium confidence
Context

Jefferies expects Molina Healthcare to post lower quarter‑over‑quarter Medicaid attrition in Q3.

Expected impact

possible slight upward pressure from improved enrollment stability

Evidence & confidence

Analyst view points to better member retention for Molina.

$UNHBullishMedium confidence
Context

Jefferies expects UnitedHealth to post lower quarter‑over‑quarter Medicaid attrition in Q3.

Expected impact

likely modest upside as reduced churn is viewed favorably

Evidence & confidence

The forecast signals improved enrollment trends for UnitedHealth.

Market effects

Medicaid attrition trends may influence broader managed‑care sector sentiment.

U.S. health‑care stocks could see slight adjustments based on enrollment outlook.

Limited to U.S. health‑care equities; minimal global spillover.

Counterpoint

If attrition data underestimates churn, stocks could face downside pressure.

Key entities

  • Jefferies

    Research firm providing the attrition forecast.

  • Humana

    Managed care organization with flat enrollment attrition.

  • Centene

    MCO expected to see lower attrition in Q3.

  • Elevance Health

    MCO expected to see lower attrition in Q3.

  • Molina Healthcare

    MCO expected to see lower attrition in Q3.

Related articles

$NVDAMed

SA analyst upgrades/downgrades: NVDA, UNH, CLSK, CAT

Seeking Alpha analysts upgraded CleanSpark (CLSK) and Caterpillar (CAT) due to positive outlooks, while downgrading Nvidia (NVDA) and UnitedHealth (UNH) citing growth risks. CLSK's upgrade follows a $6.6B lease for AI infrastructure. CAT was praised for strong Q2 results and execution. NVDA's downgrade cited inventory and supply constraints.

$HUMHigh

Why is Humana stock climbing today?

Humana (HUM) stock rose 1.4% in pre-market trading after Cantor Fitzgerald upgraded it to Overweight, raising its price target to $460 from $300. The firm cited confidence in Humana's Medicare Advantage margin recovery and improved STARS ratings, also lifting EPS forecasts for 2027 and 2028. Humana trades at 9.9x 2028 earnings, below its historical multiple. Other analysts have also expressed bullish sentiment, with Barclays and Wolfe Research maintaining Overweight/Outperform ratings.